The Center for Disease control in conjunction with state and local health departments in Maryland and Virginia as well as the Food and Drug Administration (FDA) are investigating a very serious meningitis outbreak of fungal infections among patients who have received steroid injections into their spine and possibly other parts of their body. These injections are frequently administered by doctors to alleviate spine and neck pain and other types of inflammatory or pain conditions.
The CDC has issued warnings and local authorities after suffered patients have suffered strokes that are believed to have resulted from severe meningitis infections. The infections are believed to be caused by contaminated products from New England Compounding Center’s (NECC) Framingham, Massachusetts’s facility, on October 4, and the FDA has advised providers to not use any NECC products. NECC has issued a voluntary recall of the potentially defective products.
Out of an abundance of caution, FDA has recently released statements advising physicians to follow-up with patients who received an injectable product, including an ophthalmic drug that is injectable or used in conjunction with eye surgery, as well as a cardioplegic solution purchased from or produced by the New England Compounding Center (NECC) after May 21, 2012. Patients who feel ill and are concerned about whether they received a medication from one of the NECC products recalled on September 26 should contact their physician.
The Center for Disease Control has released a statement on its website containing useful information for potential victims of the outbreak. See the FDA link below for more information. At this time, CDC is maintaining the position that the infections attributable to the defective injections are not communicable.
Maryland and Virginia patients who have been infected by these defective injections may have actionable personal injury claims and are encouraged to contact an attorney to discuss whether or not they may be entitled to compensation.